Traditional pathogen detection methods rely on the identification of pathogens known to be associated with a particular syndrome. In many cases, it involves complex methodology, lengthy procedure and time-consuming operation. Also, traditional methods often fail to identify mixed pathogens in complex clinical samples, making the diagnosis and treatment of infection challenging. As the cost of sequencing drops and technology improves, metagenomics becomes feasible. In this webinar, Dr. Kin Kuok will introduce MGI’s DNA nanoball sequencing (DNBSEQTM) and MGI’s microbial detection total solution. followed by several case studies explaining how MGI’s total solution enables fast, accurate and comprehensive microbial detection.
1. MGI is a subsidiary of BGI group. MGI’s DNA nanoball sequencing (DNBSEQTM) provides researchers an alternative sequencing platform to avoid sample contamination/index hopping and achieve higher sequencing accuracy.
2. MGI’s microbial detection total solution supports massive screening on unknown pathogens in human or animal infection, allowing accurate diagnosis and treatment.
Medical Laboratory Technician50%
Manufacturer - Other25%